Adicet Bio | 8-K: Current report
Adicet Bio | DEFR14A: Definitive proxy statement in connection with contested solicitations
Adicet Bio | ARS: Annual Report to Security Holders
Adicet Bio | DEFA14A: Others
Adicet Bio | DEF 14A: Definitive information statements
Adicet Bio | 8-K: Current report
Adicet Bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Adicet Bio | 8-K: Current report
Adicet Bio | 424B5: Prospectus
Adicet Bio | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.9%),OrbiMed Capital GP V LLC(9.2%), etc.
Adicet Bio | S-8 POS: S-8 POS
Adicet Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Adicet Bio | 8-K: Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
Adicet Bio | 10-K: Annual report
Adicet Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.2%),Millennium Group Management LLC(5.2%), etc.
Adicet Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.8%),Tang Capital Management, LLC(7.8%), etc.
Adicet Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.
Adicet Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.6%),Roderick Wong, M.D.(9.6%)
Adicet Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(6.4%)
Adicet Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.0%)
No Data